Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

Winner Medical's spunlace non-woven fabric technology wins Circular Economy Project Award

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, proudly announced today that its wholly owned subsidiary, Winner Industries Co., Ltd., was the only medical device manufacturing company to win the Circular Economy Project Award for the year 2010.

23 Mar 2011

SGEN, Abbott enter collaboration agreement for ADC products

Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.

23 Mar 2011

SMR, RTU enter license agreement for RESCULA eye drops

Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.

23 Mar 2011

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.

22 Mar 2011

Menicon opens new contact lens R&D and manufacturing facility in Singapore

Menicon Singapore, a subsidiary of Menicon Co., Ltd., Japan's first and largest contact lens manufacturer, has opened its new R&D and manufacturing facility.

22 Mar 2011

Finesse launches new core modules for off-line data processing in fourth generation TruBio DV software

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life science process applications, has announced the official launch of two new core modules for off-line data processing in its fourth generation TruBio DV software. These modules are targeted at enabling bioprocessing specialists to manage data from third party equipment and process analyzers, and obtain automated electronic records of their batch.

21 Mar 2011

Feihe fourth quarter revenues increased 41.6% to $62.3 million

Feihe International, Inc., one of the leading producers and distributors of premium infant formula, milk powder and soybean, rice and walnut products in China, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2010.

21 Mar 2011

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.

21 Mar 2011

Equipois debuts x-Ar exoskeletal arm support system for manual tasks at Applied Ergonomics Conference

Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.

21 Mar 2011

Advanced Cell Technology reduces 2010 debt to less than $1 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today 2010 year-end results for the period ended December 31, 2010. The Company utilized $8.8 million in cash for operations during the year, compared to $5.1 million in the year-earlier period.

21 Mar 2011

Medicago launches clinical development of seasonal flu vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that the first dose of vaccine has been administered thereby initiating the Company's phase I H1N1 influenza VLP vaccine candidate ("H1N1 vaccine") clinical trial in the United States. The primary safety and immunogenicity results for this trial are expected within three months.

21 Mar 2011

FDA meets ambitious implementation deadlines set forth in tobacco law

Since the passage of the Family Smoking Prevention and Tobacco Control Act in 2009, the U.S. Food and Drug Administration has met the ambitious implementation deadlines set forth in the law, the agency said Wednesday at a congressional briefing hosted by the American Association for Cancer Research.

19 Mar 2011

Researchers develop new system that documents healing process in detail

Knee patients need patience: injuries to these joints take weeks to heal. Fraunhofer researchers have now developed a system that documents the healing process in detail. This motivates patients and at the same time helps doctors to fine-tune the course of treatment.

19 Mar 2011

Protalix prices underwritten public offering of 4,000,000 shares of common stock

Protalix BioTherapeutics, Inc., announced today the pricing of its previously announced underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $5.50 per share.

18 Mar 2011

Alnylam to defend against Tekmira complaint

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is reporting the filing of a complaint by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court. The complaint alleges misappropriation and misuse of information, amongst other allegations.

18 Mar 2011

Covidien provides update on its operations in Japan

Covidien, a leading global supplier of healthcare products, today provided an update on its operations in Japan.

18 Mar 2011

Cangene second quarter revenues increase 3% to $40.2 million

Cangene Corporation today reports financial results for the quarter ended January 31, 2011, which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").

18 Mar 2011

Protalix intends to sell shares of its common stock in underwritten public offering

Protalix BioTherapeutics, Inc. announced today that it intends, subject to market conditions, to offer and sell shares of its common stock in an underwritten public offering.

18 Mar 2011

China Botanic first quarter net sales increase 32.1% to $22.6 million

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2011, and reaffirmed guidance for its full fiscal year ending October 31, 2011.

17 Mar 2011

Manufacturing News and Research

Further Reading

Cilag, POZEN enter license agreement to develop and commercialize MT 400

Winner Medical's spunlace non-woven fabric technology wins Circular Economy Project Award

SGEN, Abbott enter collaboration agreement for ADC products

SMR, RTU enter license agreement for RESCULA eye drops

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Menicon opens new contact lens R&D and manufacturing facility in Singapore

Finesse launches new core modules for off-line data processing in fourth generation TruBio DV software

Feihe fourth quarter revenues increased 41.6% to $62.3 million

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Equipois debuts x-Ar exoskeletal arm support system for manual tasks at Applied Ergonomics Conference

Advanced Cell Technology reduces 2010 debt to less than $1 million

Medicago launches clinical development of seasonal flu vaccine

FDA meets ambitious implementation deadlines set forth in tobacco law

Researchers develop new system that documents healing process in detail

Protalix prices underwritten public offering of 4,000,000 shares of common stock

Alnylam to defend against Tekmira complaint

Covidien provides update on its operations in Japan

Cangene second quarter revenues increase 3% to $40.2 million

Protalix intends to sell shares of its common stock in underwritten public offering

China Botanic first quarter net sales increase 32.1% to $22.6 million

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News